WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian … Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's …
InvestorsHub - NYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock …
Witryna27 mar 2024 · Companies. ImmunoGen Inc. (NASDAQ:IMGN) traded at $3.79 at close of the session on Friday, 03/24/23, made an upward move of 1.61% on its previous day’s price. Looking at the stock we see that its previous close was $3.73 and the beta (5Y monthly) reads 0.85 with the day’s price range being $3.66 – $3.83. In terms of its 52 … Witryna29 mar 2024 · Zooming in on an example, the ImmunoGen, Inc. ( NASDAQ:IMGN) share price dropped 66% in the last half decade. We certainly feel for shareholders who bought near the top. We also note that the ... hillside washer 1/2
ImmunoGen, Inc. (IMGN) Stock Price & News - Google Finance
Witryna1 mar 2024 · The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts. WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer … WitrynaImmunoGen Inc. (NASDAQ:IMGN) has a beta value of 0.93 and has seen 2.94 million shares traded in the last trading session. The company, currently valued at $944.08M, … smart lighting dimmer switch